Soliris

Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M
Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M
Endpoints
Alexion
Soliris
clinical trials
NMOSD
Flag link:
How badly does Alexion want its Soliris follow-on? Enough to use a rare fast pass
How badly does Alexion want its Soliris follow-on? Enough to use a rare fast pass
Biopharma Dive
Alexion
Soliris
fast pass
FDA
priority review
ALXN1210
Flag link:
Alexion's follow-on stacks up to Soliris
Alexion's follow-on stacks up to Soliris
Biopharma Dive
Alexion
Soliris
ALXN1210
paroxysmal nocturnal hemoglobinuria
PNH
Flag link:
Alexion turns focus to rebuilding pipeline amid restructuring
Alexion turns focus to rebuilding pipeline amid restructuring
Biopharma Dive
Alexion
restructuring
Soliris
Flag link:
Prepping PhIII for Soliris rival, Apellis rides a boisterous market to a $150M IPO
Prepping PhIII for Soliris rival, Apellis rides a boisterous market to a $150M IPO
Endpoints
Soliris
Apellis
Flag link:
Alexion cutting 600 jobs and moving headquarters in major shakeup
Alexion cutting 600 jobs and moving headquarters in major shakeup
Stat
Alexion
layoffs
Soliris
Flag link:
Alexion bolsters Soliris patent defense
Alexion bolsters Soliris patent defense
BioPharma Dive
Alexion
Soliris
patents
Rare Diseases
Flag link:
Alexion Being Probed by HHS Inspector General; Shares Fall
Alexion Being Probed by HHS Inspector General; Shares Fall
Bloomberg
Alexion Pharmaceuticals
HHS
Soliris
fraud
Flag link:
Top 25 rare disease brands, by sales
Top 25 rare disease brands, by sales
Medical Marketing and Media
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
Flag link:
Alexion Pharmaceuticals says CEO, CFO resign, shares slump
Alexion Pharmaceuticals says CEO, CFO resign, shares slump
Yahoo/Reuters
Alexion Pharmaceuticals
Pharma CEOs
Soliris
David Hallal
David Brennan
Flag link:
9 Drugs That Cost Medicare a Fortune
9 Drugs That Cost Medicare a Fortune
Motley Fool
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Flag link:
Will Soliris’s Label Expansion Fuel Alexion’s Growth?
Will Soliris’s Label Expansion Fuel Alexion’s Growth?
Yahoo/Market Realist
Alexion
Soliris
aHUS
Flag link:
Alexion's Soliris, Bayer's Xarelto get stiff-armed by a couple of cost gatekeepers
Alexion's Soliris, Bayer's Xarelto get stiff-armed by a couple of cost gatekeepers
Fierce Pharma
Alexion
Soliris
Bayer
Xarelto
UK
Canada
New Zealand
Flag link:
The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug
The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug
BioPharma Dive
Soliris
Alnylam
Alexion
PNH
Flag link:
Alnylam Going After World's Most Expensive Drug in New Trials
Alnylam Going After World's Most Expensive Drug in New Trials
Bloomberg
Alnylam
ALN-CC5
Soliris
PNH
Flag link:
This Drugmaker's Incredible Run Looks Far From Done
This Drugmaker's Incredible Run Looks Far From Done
Motley Fool
Alexion
aHUS
Soliris
Flag link:
Omeros Corporation: Another Biotech Bubble In The Making?
Omeros Corporation: Another Biotech Bubble In The Making?
Yahoo/Benzinga
Omeros
OMS721
Soliris
aHUS
Flag link:
The 5 Most Expensive Drugs in the World in 2015
The 5 Most Expensive Drugs in the World in 2015
Motley Fool
drug pricing
Glybera
Soliris
Naglazyme
Vimizim
Elaprase
Shire
Biomarin
Alexion
uniQure
Flag link:
Big Pharmas back Ra's $58.5M bet on a rival to Soliris
Big Pharmas back Ra's $58.5M bet on a rival to Soliris
Fierce Biotech
Ra Pharmaceuticals
Alexion
Soliris
C5 inhibitor
RA101495
Flag link:
Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued
Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued
Yahoo/Benzinga
Alexion
AXLN1007
Soliris
Flag link:

Pages